Varaico: Literature-Extracted Genetic Variants

Gene:HRAS
Variant:p.G12A
Back to variants list

HRAS

NM_005343.4:p.G12A

Associated Papers

Genomic Profile of Non-Small Cell Lung Cancer in a Spanish Cohort: A 2-Year Descriptive Study Using Next-Generation Sequencing.

Carnero-Gregorio M et al.

Genes, 2026

Evolving Features of RASopathies Among Pregnancies With Abnormal Fetal Fluid Collections.

Gulrajani NB et al.

Prenatal Diagnosis, 2025

Functional Analysis of Rare RAS Variants of Unknown Significance.

Park S et al.

Cancer Research Communications, 2025

40970755 (PubMed )
Supplement: crc-25-0188_supplementary_table_s4_suppst4.xlsx › Supplementary_Table_S4

PIK3CB Inhibitor GSK2636771 in Cancers With PTEN Mutation/Deletion or Loss of PTEN Protein Expression: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols N and P.

Janku F et al.

Jco Precision Oncology, 2025

40865033 (PubMed )
Supplement: protocol2_PO-25-00265.pdf

Advances and Challenges in RAS Signaling Targeted Therapy in Leukemia.

Chen Y et al.

Molecular Cancer Therapeutics, 2025

Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS-positive variant patients.

Bessis D et al.

Journal of the European Academy of Dermatology and Venereology : Jeadv, 2024

Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations.

Detiger SE et al.

Clinical Immunology (orlando, Fla.), 2024

Scalable approaches for generating, validating and incorporating data from high-throughput functional assays to improve clinical variant classification.

Padigepati SR et al.

Human Genetics, 2024

39085601 (PubMed )
Supplement: 439_2024_2691_MOESM2_ESM.xlsx › HRAS

KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways.

Mondal K et al.

Cells, 2024

Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy.

Osumi H et al.

Nature Communications, 2024

RASopathies - what they reveal about RAS/MAPK signaling in skeletal muscle development.

Rauen KA et al.

Disease Models & Mechanisms, 2024

Adult syndromology: challenges, opportunities and perspectives: Illustrated by the description of four adults with Costello syndrome.

Schmetz A et al.

Medizinische Genetik : Mitteilungsblatt Des Berufsverbandes Medizinische Genetik E.v, 2024

Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of Thyroid Cancer.

Fu G et al.

Jama Network Open, 2024

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.

Holderfield M et al.

Nature, 2024

38589574 (PubMed )
Supplement: 41586_2024_7205_MOESM5_ESM.xlsx › Fig_2

Mosaic RASopathies concept: different skin lesions, same systemic manifestations?

Morren MA et al.

Journal of Medical Genetics, 2024

The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors.

Kareff SA et al.

Cancers, 2024

HRAS-Mutant Cardiomyocyte Model of Multifocal Atrial Tachycardia.

Rodríguez NA et al.

Circulation. Arrhythmia and Electrophysiology, 2024

Targeting KRAS in cancer.

Singhal A et al.

Nature Medicine, 2024

The evolutionary impact of childhood cancer on the human gene pool.

Stoltze UK et al.

Nature Communications, 2024

38424437 (PubMed )
Supplement: 41467_2024_45975_MOESM4_ESM.xlsx › Supplementary_Data_33

In-Depth Genomic Analysis: The New Challenge in Congenital Heart Disease.

Nappi F

International Journal of Molecular Sciences, 2024

The rapidly changing field of predictive biomarkers of non-small cell lung cancer.

Tóth LJ et al.

Pathology Oncology Research : Por, 2024

Structural modifications and kinetic effects of KRAS interactions with HRAS and NRAS: an in silico comparative analysis of KRAS mutants.

Silverman I et al.

Frontiers in Molecular Biosciences, 2024

Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.

Hirose K et al.

Head and Neck Pathology, 2023

RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma.

Mustansar T et al.

Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission, 2023

Characteristics and prognostic analysis of patients with detected KRAS mutations in resected lung adenocarcinomas by peptide nucleic acid-locked nucleic acid polymerase chain reaction (PNA-LNA PCR) clamp method.

Hashimoto T et al.

Translational Lung Cancer Research, 2023

Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC.

Sakthikumar S et al.

Veterinary and Comparative Oncology, 2023

37248814 (PubMed )
Supplement: supplement_1.xlsx › Supp._Table_5

A very mild phenotype in six individuals of a three-generation family with the novel HRAS variant c.176C > G p.(Ala59Gly): Emergence of a new HRAS-related RASopathy distinct from Costello syndrome.

Frey T et al.

American Journal of Medical Genetics. Part A, 2023

Generation of novel complete HLA class I monoallelic cell lines used in an MHC stabilization assay for neoantigen evaluation.

Iizuka A et al.

Oncology Letters, 2023

37415627 (PubMed )
Supplement: Supplementary_Data2.pdf

Fatal leukodystrophy in Costello syndrome: a case report.

Failoc-Rojas VE et al.

Bmc Pediatrics, 2023

CRISPR prime editing for unconstrained correction of oncogenic KRAS variants.

Jang G et al.

Communications Biology, 2023

Analysis of H-ras Mutations and Immunohistochemistry in Recurrence Cases of High-Grade Oral Squamous Cell Carcinoma.

Hamidavi Asl A et al.

Head and Neck Pathology, 2023

Cancer in Costello syndrome: a systematic review and meta-analysis.

Astiazaran-Symonds E et al.

British Journal of Cancer, 2023

Rapid exome sequencing as a first-tier test in neonates with suspected genetic disorder: results of a prospective multicenter clinical utility study in the Netherlands.

Olde Keizer RACM et al.

European Journal of Pediatrics, 2023

36997769 (PubMed )
Supplement: 431_2023_4909_MOESM4_ESM.xlsx › Supplementary_T3

Use of dual genomic sequencing to screen mitochondrial diseases in pediatrics: a retrospective analysis.

Wu TH et al.

Scientific Reports, 2023

36918699 (PubMed )
Supplement: 41598_2023_31134_MOESM1_ESM.pdf

KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients.

Mirzapoor Abbasabadi Z et al.

Journal of Clinical Laboratory Analysis, 2023

Syndromic forms of congenital hyperinsulinism.

Zenker M et al.

Frontiers in Endocrinology, 2023

37065762 (PubMed )
Supplement: Table_1.xlsx › Costello

Case Report: Longitudinal monitoring of clonal evolution by circulating tumor DNA for resistance to anti-EGFR antibody in a case of metastatic colorectal cancer.

Sagawa T et al.

Frontiers in Oncology, 2023

Case Report: Sequential postzygotic HRAS mutation and gains of the paternal chromosome 11 carrying the mutated allele in a patient with epidermal nevus and rhabdomyosarcoma: evidence of a multiple-hit mechanism involving HRAS in oncogenic transformation.

Zuntini R et al.

Frontiers in Genetics, 2023

Gastrointestinal Stromal Tumours (GISTs) with KRAS Mutation: A Rare but Important Subset of GISTs.

Mullen D et al.

Case Reports in Gastrointestinal Medicine, 2023

Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island.

Li B et al.

Peerj, 2023

38050610 (PubMed )
Supplement: peerj-11-16392-s001.zip › Raw_data › sup-0003-tables3.xlsx › sheet1

Cancer incidence and surveillance strategies in individuals with RASopathies.

Ney G et al.

American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 2022

Diagnostic yield using whole-genome sequencing and in-silico panel of 281 genes associated with non-immune hydrops fetalis in clinical setting.

Westenius E et al.

Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2022

Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.

White JA et al.

Cancer Research Communications, 2022

36922933 (PubMed )
Supplement: crc-22-0136-s01.xlsx › ST3_Known_Somatic_Variants

Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers.

Cekani E et al.

Cancers, 2022

Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group.

Toss A et al.

Current Oncology Reports, 2022

HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models.

Dard L et al.

The Journal of Clinical Investigation, 2022

Mitochondria and the future of RASopathies: the emergence of bioenergetics.

Kontaridis MI et al.

The Journal of Clinical Investigation, 2022

Clinical and molecular characterization of Costello syndrome in unrelated Mexican patients.

Ríos-González BE et al.

Clinical Dysmorphology, 2022

Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making.

Leoni C et al.

Clinical Genetics, 2022

1–50 of 206 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."